[Immunosuppressive therapy with cyclosporin A following penetrating keratoplasty].
Report on 11 patients who underwent penetrating keratoplasty and were treated with Cyclosporin A for an average of 6 months because of excessive superficial and deep vascularization of the recipient cornea. In none of the patients was a permanent Cyclosporin A-induced side-effect observed. After an average follow-up period of 11 months 9 grafts remained completely clear; however, an allograft-reaction occurred in 2 cases in spite of the immunosuppressive therapy.
D003316:Corneal Diseases / Q000601:surgery*; D016039:Corneal Transplantation; D003524:Cyclosporins / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D008297:Male
D003524:Cyclosporins
Immunsuppressive Therapie mit Cyclosporin A nach perforierender Keratoplastik.